This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Shah, N M Articles by Hughes, G R. Search for Related Content PubMed PubMed Citation Articles by Shah, N M Articles by Hughes, G R. Social Bookmarking                         What's this?

Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients

M A Khamashta

T Atsumi

G RV Hughes

Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital, London SE1 7EH, UK

We report a 10-year follow-up on 52 patients with raised levels of anticardiolipin antibodies (aCL) who were first seen at our tertiary referral centre in 1986. The clinical and serological features of these 52 patients are described. Thirty-one patients had the antiphospholipid syndrome (APS) in 1986. Nine of these patients (29%) had further thrombotic events during the follow-up period. Of the other 21 aCL positive patients without clinical manifestations of APS, 11 (52%) developed the syndrome over this period. Five patients (10%) died during the follow-up. Close monitoring of patients with connective tissue diseases and aCL is essential as the likelihood of developing antiphospholipid syndrome is high.

Key Words: antiphospholipid antibodies • antiphospholipid syndrome • thrombosis • pregnancy loss

Lupus, Vol. 7, No. 1, 3-6 (1998)
DOI: 10.1191/096120398678919624


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Evangelopoulos, S Toumanidis, D Sotou, C Evangelopoulos, M Mavrikakis, M Alevizaki, and M. Dimopoulos Mitral valve prolapse in young healthy individuals. An early index of autoimmunity? Lupus, April 1, 2009; 18(5): 436 - 440. [Abstract] [PDF]

				A Ruffatti, T D. Ross, M Ciprian, M Nuzzo, M Rampudda, M T Bertero, R Bergia, P Caramaschi, D Biasi, F Capsoni, et al. Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study Ann Rheum Dis, March 1, 2009; 68(3): 397 - 399. [Abstract] [Full Text] [PDF]

				E Matsuura and L. Lopez Autoimmune-mediated atherothrombosis Lupus, October 1, 2008; 17(10): 879 - 888. [Abstract] [PDF]

				T. Hereng, M. Lambert, E. Hachulla, M. Samor, S. Dubucquoi, C. Caron, D. Launay, S. Morell-Dubois, V. Queyrel, and P.-Y. Hatron Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients Lupus, January 1, 2008; 17(1): 11 - 15. [Abstract] [PDF]

				A. Tincani, M. Nuzzo, A. Lojacono, M. Cattalini, and A. Meini Review: Contraception in adolescents with systemic lupus erythematosus Lupus, August 1, 2007; 16(8): 600 - 605. [Abstract] [PDF]

				T Tarr, G Lakos, H P Bhattoa, Y Shoenfeld, G Szegedi, and E Kiss Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients Lupus, January 1, 2007; 16(1): 39 - 45. [Abstract] [PDF]

				I. Giles, N. Lambrianides, N. Pattni, D. Faulkes, D. Latchman, P. Chen, S. Pierangeli, D. Isenberg, and A. Rahman Arginine Residues Are Important in Determining the Binding of Human Monoclonal Antiphospholipid Antibodies to Clinically Relevant Antigens J. Immunol., August 1, 2006; 177(3): 1729 - 1736. [Abstract] [Full Text] [PDF]

				M M Shinzato, C Bueno, V S T. Viana, E F Borba, C R Goncalves, and E Bonfa Complement-fixing activity of anticardiolipin antibodies in patients with and without thrombosis Lupus, December 1, 2005; 14(12): 953 - 958. [Abstract] [PDF]

				K. T. Ho, C. W. Ahn, G. S. Alarcon, B. A. Baethge, F. K. Tan, J. Roseman, H. M. Bastian, B. J. Fessler, G. McGwin Jr, L. M. Vila, et al. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events Rheumatology, October 1, 2005; 44(10): 1303 - 1307. [Abstract] [Full Text] [PDF]

				T. Akimoto, S. Kobayashi, N. Tamura, T. Ohsawa, T. Kawano, M. Tanaka, and H. Hashimoto Risk Factors for Recurrent Thrombosis: Prospective Study of a Cohort of Japanese Systemic Lupus Erythematosus Angiology, September 1, 2005; 56(5): 601 - 609. [Abstract] [PDF]

				S. Quenby, R.G. Farquharson, F. Dawood, A.M. Hughes, and J. Topping Recurrent miscarriage and long-term thrombosis risk: a case-control study Hum. Reprod., June 1, 2005; 20(6): 1729 - 1732. [Abstract] [Full Text] [PDF]

				S. Ferreira, D. P. D'Cruz, and G. R. V. Hughes Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology, April 1, 2005; 44(4): 434 - 442. [Abstract] [Full Text] [PDF]

				A. Rahman Autoantibodies, lupus and the science of sabotage Rheumatology, November 1, 2004; 43(11): 1326 - 1336. [Abstract] [Full Text] [PDF]

				M E Evangelopoulos, M Alevizaki, S Toumanidis, D Sotou, C D Evangelopoulos, D A Koutras, S F Stamatelopoulos, and M Mavrikakis Mitral valve prolapse in systemic lupus erythematosus patients: clinical and immunological aspects Lupus, April 1, 2003; 12(4): 308 - 311. [Abstract] [PDF]

				D. K. Tack, T. Paisansinsup, and S. Amin 44-Year-Old Woman With Fatigue and Dyspnea Mayo Clin. Proc., March 1, 2003; 78(3): 341 - 344. [PDF]

				M. Galli, D. Luciani, G. Bertolini, and T. Barbui Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature Blood, March 1, 2003; 101(5): 1827 - 1832. [Abstract] [Full Text] [PDF]

				G. Sanna, M. L. Bertolaccini, M. J. Cuadrado, M. A. Khamashta, and G. R. V. Hughes Central nervous system involvement in the antiphospholipid (Hughes) syndrome Rheumatology, February 1, 2003; 42(2): 200 - 213. [Abstract] [Full Text] [PDF]

				G R V Hughes Migraine, memory loss, and "multiple sclerosis ". Neurological features of the antiphospholipid (Hughes') syndrome Postgrad. Med. J., February 1, 2003; 79(928): 81 - 83. [Abstract] [Full Text] [PDF]

				T. E. Warkentin, W. C. Aird, and J. H. Rand Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome Hematology, January 1, 2003; 2003(1): 497 - 519. [Abstract] [Full Text] [PDF]

				R. L. Brey, C. L. Stallworth, D. L. McGlasson, M. A. Wozniak, R. J. Wityk, B. J. Stern, M. A. Sloan, R. Sherwin, T. R. Price, R. F. Macko, et al. Antiphospholipid Antibodies and Stroke in Young Women * Editorial Comment Stroke, October 1, 2002; 33(10): 2396 - 2401. [Abstract] [Full Text] [PDF]

				B. G. Macik, J. H. Rand, and B. A. Konkle Thrombophilia: What's a Practitioner to Do? Hematology, January 1, 2001; 2001(1): 322 - 338. [Abstract] [Full Text] [PDF]

				M.G. Tektonidou, J.P.A. Ioannidis, K.A. Boki, P.G. Vlachoyiannopoulos, and H.M. Moutsopoulos Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome QJM, August 1, 2000; 93(8): 523 - 530. [Abstract] [Full Text] [PDF]

				R. Brey and A. Escalante Review : Neurological manifestations of antiphospholipid antibody syndrome Lupus, January 1, 1998; 7(2_suppl): S67 - S74. [Abstract] [PDF]

				M. Khamashta Review : Management of thrombosis and pregnancy loss in the antiphospholipid syndrome Lupus, January 1, 1998; 7(2_suppl): S162 - S165. [Abstract] [PDF]